Tissue injury caused by the spread of this epitope leads to the formation of various lesions; Longshan et al. reported that CHST4 may recruit immune cells into the tumor microenvironment and prevent the progression of hepatitis B virus-related hepatocellular carcinoma [9]. Here, CHST4 is linked to hepatocellular carcinoma.